Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study

References

• Raggi P, Genest J, Giles JT, et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 2018;276:98–108. PMID: 30055326.
   PubMed Web of Science ®Google Scholar
• Swerdlow DI, Holmes MV, Kuchenbaecker KB, et al. Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214–1224.
   PubMed Web of Science ®Google Scholar
• Interleukin 1 Genetics Consortium. Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a mendelian randomisation analysis. Lancet Diabetes Endocrinol. 2015;3:243–253.
   PubMed Web of Science ®Google Scholar
• Elkind MS, Luna JM, Moon YP, et al. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurology. 2009;73:1300–1307.
   PubMed Web of Science ®Google Scholar
• Matteini AM, Li J, Lange EM, et al. Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults. Cytokine. 2014;65:10–16.
   PubMed Web of Science ®Google Scholar
• Jenny NS, Callas PW, Judd SE, et al. Inflammatory cytokines and ischemic stroke risk: the REGARDS cohort. Neurology. 2019;92:e2375–e2384.
   PubMed Web of Science ®Google Scholar
• Rosa M, Chignon A, Li Z, et al. A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity. NPJ Genom Med. 2019;4:23.
   PubMed Web of Science ®Google Scholar
• Prins BP, Abbasi A, Wong A, et al. Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium mendelian randomization study. PLoS Med. 2016;13:e1001976.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang A, Zhang J, et al. Association of plasma C-reactive protein with ischemic stroke: a mendelian randomization study. Eur J Neurol. 2019. Epub ahead of print. DOI:10.1111/ene.14113.
   Web of Science ®Google Scholar
• Sarwar N, Butterworth AS, Freitag DF, et al.; IL6R Genetics Consortium Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379:1205–1213.
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133–1163.
   PubMed Web of Science ®Google Scholar
• Hartwig FP, Borges MC, Horta BL, et al. Inflammatory biomarkers and risk of schizophrenia: a 2-sample mendelian randomization study. JAMA Psychiatry. 2017;74:1226–1233.
   PubMed Web of Science ®Google Scholar
• Dehghan A, Dupuis J, Barbalic M, et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123:731–738.
   PubMed Web of Science ®Google Scholar
• Wensley F, Gao P, Burgess S, et al.; C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC). Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011;342:d548.
   PubMed Web of Science ®Google Scholar
• Malik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50:524–537.
   PubMed Web of Science ®Google Scholar
• Thomas DC, Lawlor DA, Thompson JR. Re: estimation of bias in nongenetic observational studies using “Mendelian triangulation” by Bautista et al. Ann Epidemiol. 2007;17:511–513.
   PubMed Web of Science ®Google Scholar
• Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–665.
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–314.
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–525.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131.
   PubMed Web of Science ®Google Scholar
• Cainzos-Achirica M, Enjuanes C, Greenland P, et al. The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2018;278:217–225.
   PubMed Web of Science ®Google Scholar
• Ziegler L, Gajulapuri A, Frumento P, et al. Interleukin 6 trans-signalling and risk of future cardiovascular events. Cardiovasc Res. 2019;115:213–221.
   PubMed Web of Science ®Google Scholar
• Elliott P, Chambers JC, Zhang W, et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA. 2009;302:37–48.
   PubMed Web of Science ®Google Scholar
• Penson PE, Long DL, Howard G, et al. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study. Eur Heart J. 2018;39:3641–3653.
   PubMed Web of Science ®Google Scholar
• Lambertsen KL, Finsen B, Clausen BH. Post-stroke inflammation-target or tool for therapy? Acta Neuropathol. 2019;137:693–714.
   PubMed Web of Science ®Google Scholar
• Billinger SA, Sisante JV, Mattlage AE, et al. The relationship of pro-inflammatory markers to vascular endothelial function after acute stroke. Int J Neurosci. 2017;127:486–492.
   PubMed Web of Science ®Google Scholar
• Georgakis MK, Gill D, Rannikmäe K, et al. Genetically determined levels of circulating cytokines and risk of stroke. Circulation. 2019;139:256–268.
   PubMed Web of Science ®Google Scholar
• Ligthart S, de Vries PS, Uitterlinden AG, et al. Pleiotropy among common genetic loci identified for cardiometabolic disorders and C-reactive protein. PLoS One. 2015;10:e0118859.
   PubMed Web of Science ®Google Scholar